Volume | 245,801 |
|
|||||
News | - | ||||||
Day High | 0.448699 | Low High |
|||||
Day Low | 0.41 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Curis Inc | CRIS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.4193 | 0.41 | 0.448699 | 0.4231 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
496 | 245,801 | $ 0.4379358 | $ 107,645 | - | 0.41 - 1.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:32:36 | 10 | $ 0.43 | USD |
Curis Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
48.85M | 117.70M | - | 10.16M | -56.67M | -0.48 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Curis News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRIS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.4549 | 0.4638 | 0.41 | 0.4376676 | 205,843 | -0.0399 | -8.77% |
1 Month | 0.589 | 0.59 | 0.41 | 0.4982578 | 271,103 | -0.174 | -29.54% |
3 Months | 0.81 | 0.90 | 0.41 | 0.666237 | 326,077 | -0.395 | -48.77% |
6 Months | 0.53 | 1.00 | 0.41 | 0.7472352 | 331,232 | -0.115 | -21.7% |
1 Year | 0.7095 | 1.00 | 0.41 | 0.705003 | 503,994 | -0.2945 | -41.51% |
3 Years | 1.09 | 17.40 | 0.41 | 5.61 | 2,322,755 | -0.675 | -61.93% |
5 Years | 1.62 | 17.40 | 0.41 | 4.89 | 1,693,216 | -1.21 | -74.38% |
Curis Description
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. |